The suppression of ERα expression in VMH alters the anorexigenic effect of E2 treatment, leading to obesity, hyperphagia, and reduced energy expenditure in female mice and rats [(81), Figure 1]. Here, ESR1 is linked to obesity due to melanocortin 4 receptor deficiency.